Tuberculosis Control in Asia and the Western Pacific: A Role for Computer Modelling

Annals of the Academy of Medicine Singapore

Volumn 26, Issue 5, 1997, Pages 642-646

  Brewer, T F ^a,b,d   Heymann, S J ^c   Harris, J B ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Intl Soc for Infectious Diseases   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d CHANNING LABORATORY   (United States)

Author keywords

Decision analysis; Human immunodeficiency virus; Prevention; Public health; Treatment

Indexed keywords

AIDS RELATED COMPLEX; ASIA; COMPUTER; COMPUTER SIMULATION; DEVELOPING COUNTRY; DISEASES; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTIONS; INFORMATION; INFORMATION PROCESSING; LITERATURE REVIEW; METHODOLOGY; PACIFIC ISLANDS; REVIEW; THEORETICAL MODEL; TREATMENT; TUBERCULOSIS; TUBERCULOSIS--PREVENTION AND CONTROL; VIRAL DISEASES;

ASIA; COMPUTERS; DEVELOPING COUNTRIES; DISEASES; HIV INFECTIONS; INFECTIONS; INFORMATION; INFORMATION PROCESSING; LITERATURE REVIEW; MODELS, THEORETICAL; RESEARCH METHODOLOGY; TREATMENT; TUBERCULOSIS--PREVENTION AND CONTROL; VIRAL DISEASES;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ASIA; COMPUTER SIMULATION; HUMANS; PACIFIC ISLANDS; TUBERCULOSIS;

EID: 0031217179     PISSN: 03044602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Sudre P, ten Dam H G, Kochi A. Tuberculosis: a global overview of the situation today Bull World Health Organ 1992; 70 149-59
2. Raviglione M C, Snider D E, Kochi A. Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. JAMA 1995; 273 220-6
3. Murray C, Styblo K, Rouillon A. Tuberculosis. New York: World Bank, Health Sector Priorities Review. No. 24, 1991.
4. Aditama T Y. Prevalence of tuberculosis in Indonesia, Singapore, Brunei Darussalam and the Philippines. Tubercle 1991; 72.255-60.
5. Dolin P J, Raviglione M C, Kochi A. Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ 1994; 72:213-20
6. Kochi A, Vareldiz B, Styblo K Multidrug-resistant tuberculosis and its control. Res Microbiol 1993; 144:104-10.
7. Jain N K. Drug resistance in India: a tragedy in the making, Indian J Tuber 1992; 39:145-8.
8. Yanai H, Uthaivoravit W, Panich V, Sawanpanyalert P, Chaimanee B, Akarasewi P, et al. Rapid increase in HIV-related tuberculosis, Chiang Rai, Thailand, 1990-1994. AIDS 1996; 10 527-31
9. Prabhakar R. Tuberculosis - the continuing scourge of India. Indian J Med Res 1996; 103:19-25
10. Nunn P P, Elliott A M, McAdam K P W J. Impact of human immunodeficiency virus on tuberculosis in developing countries. Thorax 1994; 49:511-8.
11. Solomon S, Anuradha S, Rajasekaran S. Trend in HIV infection in patients with pulmonary tuberculosis in south India. Tuber Lung Dis 1995; 76:17-9.
12. Goble M, Iseman M D, Madsen L A, Waite D, Ackerson L, Horsburgh C R Jr. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin N Engl J Med 1993; 328:527-32.
13. Indian Council of Medical Research. Prevalence of drug resistance in patients with pulmonary tuberculosis presenting for the first time with symptoms at chest clinics in India. Part II. Findings in urban clinics among all patients, with or without history of previous chemotherapy. Indian J Med Res 1969, 57 823-35.
14. Howells G. Primary drug resistance in Australia in 1968. Tubercle 1969; 50:344-9.
15. Kim S, Hong Y. Drug resistance of Mycobacterium tuberculosis in Korea. Tuber Lung Dis 1992, 73:219-24
16. Gupta P R, Singhal B, Sharma T N, Gupta R B Prevalence of initial drug resistance in tuberculosis patients attending a chest hospital. Indian J Med Res [A] 1993; 97:102-3.
17. Centers for Disease Control. A strategic plan for the elimination of tuberculosis in the United States. Morb Mortal Wkly Rep 1989, 38(Suppl 3):1-23.
18. Blower S M, McLean A R. Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco. Science 1994; 265:1451-4.
19. Heymann SJ. Modelling the efficacy of prophylactic and curative therapies for preventing the spread of tuberculosis in Africa Trans R Soc Trop Med Hyg 1993; 87 406-11.
20. Brewer T F, Heymann S J, Colditz G A, Wilson M E, Auerbach M S, Kane D, et al. Evaluation of tuberculosis control policies using computer simulation. JAMA 1996, 276:1898-903.
21. Pape J W, Jean S S, Ho J L, Hafner A, Johnson W D Jr. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 1993, 342:268-72.
22. World Health Organization. WHO Report on the tuberculosis epidemic, 1995. WHO/TB/95.183.
23. China Tuberculosis Control Collaboration. Results of directly observed short-course chemotherapy in 112,842 Chinese patients with smear-positive tuberculosis. Lancet 1996; 347:358-62
24. Curtis R, Friedman S R, Neaigus A, Jose B, Goldstein M, Des Jarlais D C. Implications of directly observed therapy in tuberculosis control measures among IDUs. Public Health Rep 1994; 109:319-27.
25. Asch S, Leake B, Gelberg L. Does fear of immigration authorities deter tuberculosis patients from seeking care? West J Med 1994; 161 373-6
26. Heymann S J, Sell R, Brewer T F. The influence of programme acceptability on the effectiveness of public health policy. A study of directly observed therapy for tuberculosis. Am J Public Health 1997. (In press).
27. Annas G J. Control of tuberculosis - the law and the public's health N Engl J Med 1993; 328:585-8
28. Blower S M, Small P M, Hopewell P C. Control strategies for tuberculosis epidemics: New models for old problems. Science 1996; 273.497-500
29. Blower S M, McLean A R, Porco T C, Small P M, Hopewell P C, Sanchez M A, et al. The intrinsic transmission dynamics of tuberculosis epidemics. Nature Med 1995; 1:815-21.
30. Brewer T F, Heymann S J, Ettling M. An effectiveness and cost analysis of presumptive treatment for Mycobacterium tuberculosis. Am J Infect Control 1997. (In press).
31. Murray C J L, DeJonghe E, Chum H J, Nyangulu D S, Salomao A, Styblo K. Cost effectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan African countries. Lancet 1991; 338:1305-8.
32. Joesoef M R, Remington P L, Tjiptoherijanto P. Epidemiological model and cost-effectiveness analysis of tuberculosis treatment programmes in Indonesia. Int J Epidemiol 1989; 18:174-9.